Form D · Biotechnology

Translate Bio, Inc.

Lexington, MA · CIK 0001693415

Offering snapshot reported May 10, 2019 · SEC filing

Reported sold
$47.5M
Offering amount: $47.5M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 3, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 10, 2019Initial$47,454,990No comparison22SEC filing
Jan 5, 2017Initial$50,999,987No comparison25SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$2.85M
Finders' fees
$0
Form D file number
021-339369

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jefferies LLC2347
SVB Leerink LLC39011

Source: Form D, filed May 10, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ann Barbier Executive
Daniella Beckman Director
Paul Burgess Executive
Paula Cloghessy Executive
Brian Fenton Executive
Jean Francois Formela Director
Jean Francois Formela Director
Brian Gallagher Director
Michael Heartlein Executive
Owen Hughes Director
Daniel S. Lynch Director
Thomas Mc Cauley Executive
Robert J. Meyer Director
Robert M. Plenge Director
Ronald Renaud, Jr. Director, Executive
John R. Schroer Executive
Richard Wooster Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
29 Hartwell Avenue
Lexington, MA, 02421